Dashboard
Manage Tickers

HEPAHepion Pharmaceuticals, Inc.

Nasdaq hepionpharma.com


$ 1.28 $ 0.02 (1.61 %)    

Friday, 31-May-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ -0.84 (-0.19 %)
DIA $ 398.57 $ 6.05 (1.59 %)
SPY $ 530.36 $ 4.76 (0.91 %)
TLT $ 91.26 $ 0.61 (0.68 %)
GLD $ 225.37 $ -1.27 (-0.59 %)
$ 1.26
$ 1.28
$ 0.00 x 0
$ 0.00 x 0
$ 1.28 - $ 1.28
$ 1.06 - $ 12.88
16,270
na
5M
$ 1.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-21-2024 03-31-2024 10-Q
2 04-16-2024 12-31-2023 10-K
3 11-20-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 04-10-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 04-08-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 08-12-2020 06-30-2020 10-Q
17 06-30-2020 03-31-2020 10-Q
18 05-14-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 03-14-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 11-14-2017 09-30-2017 10-Q
27 09-28-2017 06-30-2017 10-K
28 04-12-2017 03-31-2017 10-Q
29 02-14-2017 12-31-2016 10-Q
30 11-14-2016 09-30-2016 10-Q
31 09-28-2016 06-30-2016 10-K
32 05-13-2016 03-31-2016 10-Q
33 02-12-2016 12-31-2015 10-Q
34 11-12-2015 09-30-2015 10-Q
35 09-25-2015 06-30-2015 10-K
36 05-14-2015 03-31-2015 10-Q
37 02-12-2015 12-31-2014 10-Q
38 11-13-2014 09-30-2014 10-Q
39 09-29-2014 06-30-2014 10-K
40 05-15-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

sp-500-rises-over-1-zions-bancorp-shares-gain-after-q1-earnings
S&P 500 Rises Over 1%; Zions Bancorp Share...
04/22/2024 18:46:36

why-is-liver-disease-drug-developer-hepion-pharmaceuticals-stock-trading-lower-on-monday
Why Is Liver-Disease Drug Developer Hepion...
04/22/2024 18:14:15

Updates on Hepion Pharmaceuticals' ASCEND-NASH Trial, now in wind-down phase. Explore insights into Phase 2b study progress...

why-vaxxinity-shares-are-trading-lower-by-around-55-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Vaxxinity Shares Are Trading Lower By ...
04/22/2024 17:26:48

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
04/22/2024 16:31:48

gold-falls-sharply-matterport-shares-spike-higher
Gold Falls Sharply; Matterport Shares Spik...
04/22/2024 16:07:37

dow-jumps-over-100-points-chicago-fed-national-activity-rises-in-march
Dow Jumps Over 100 Points; Chicago Fed Nat...
04/22/2024 13:41:41

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
04/22/2024 12:07:03

hepion-pharmaceuticals-says-given-the-number-of-enrolled-nash-patients-to-date-and-the-low-probability-of-generating-relevant-efficacy-data-to-support-a-registrational-trial-with-our-current-cash-resources-we-have-opted-to-wind-down-the-program-and-assure-that-patients-are-transitioned-out-of-the-trial-in-a-safe-and-compliant-manner
Hepion Pharmaceuticals Says Given The Numb...
04/19/2024 21:06:26

"We are disappointed to announce the wind-down of our Phase 2 NASH trial, which we attribute entirely to resource constrain...

hepion-pharmaceuticals-shares-resumed-trading
Hepion Pharmaceuticals Shares Resumed Trading
04/19/2024 21:05:32

trading-halt-halt-status-updated-at-45500-pm-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 4:55:...
04/19/2024 20:55:05

hepion-pharmaceuticals-initiates-wind-down-activities-in-phase-2b-ascend-nash-trial
Hepion Pharmaceuticals Initiates Wind-Down...
04/19/2024 20:33:05

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for...

trading-halt-halted-at-42520-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 4:25:20 p.m. ET - ...
04/19/2024 20:25:24

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
02/19/2024 13:05:48

hepion-pharmaceuticals-announces-immediate-exercise-of-series-b-common-stock-purchase-warrant-of-980393-shares-for-gross-proceeds-of-approximately-2m
Hepion Pharmaceuticals Announces Immediate...
02/16/2024 13:10:13

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
02/16/2024 13:06:00

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
02/15/2024 17:31:05

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
12/12/2023 21:31:09

brookline-capital-downgrades-hepion-pharmaceuticals-to-hold
Brookline Capital Downgrades Hepion Pharma...
12/07/2023 19:22:32

Brookline Capital analyst Kumaraguru Raja downgrades Hepion Pharmaceuticals (NASDAQ:HEPA) from Buy to Hold.

hepion-pharmaceuticals-shares-resume-trade
Hepion Pharmaceuticals Shares Resume Trade
12/07/2023 13:30:51

hepion-pharm-inc-shares-to-resume-trade-at-830-am-et
Hepion Pharm, Inc. Shares To Resume Trade ...
12/07/2023 13:08:36

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION